Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaccitech Plc ADR (NQ: VACC )

2.435 -0.065 (-2.60%)
Streaming Delayed Price Updated: 3:32 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,393
Open 2.520
Bid (Size) 2.370 (1)
Ask (Size) 2.480 (1)
Prev. Close 2.500
Today's Range 2.434 - 2.540
52wk Range 2.020 - 7.450
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vaccitech: Q1 Earnings Insights
 
Via Benzinga
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
From Vaccitech plc
Via GlobeNewswire

Performance

YTD
+1.46%
+1.46%
1 Month
+5.41%
+5.41%
3 Month
-7.06%
-7.06%
6 Month
+2.74%
+2.74%
1 Year
-43.37%
-43.37%

More News

Read More
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Via InvestorPlace
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
From Vaccitech plc
Via GlobeNewswire
Vaccitech Earnings Perspective: Return On Capital Employed
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Crude Oil Down 1%; US Composite PMI Jumps In March
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Looking Into Vaccitech's Return On Capital Employed
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions
From Vaccitech plc
Via GlobeNewswire
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
From Vaccitech plc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.